Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
farmakoterapeuttinen ryhmä: dopamiiniagonisti atc-koodi:
pharmacotherapeutic group:dopamine agonist, atc code:
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
farmakodynamiikka farmakoterapeuttinen ryhmä: dopamiiniagonisti atc-koodi:
36/94 pharmacotherapeutic group:dopamine agonist, atc code:
Last Update: 2008-03-04
Usage Frequency: 3
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
aistiharhojen tiedetään olevan dopamiiniagonisti- ja levodopahoidon haittavaikutus.
hallucinations are known as a side effect of treatment with dopamine agonists and levodopa.
Last Update: 2017-04-26
Usage Frequency: 14
Quality:
19 aistiharhojen tiedetään olevan dopamiiniagonisti - ja levodopahoidon haittavaikutus.
19 hallucinations are known as an adverse event of treatment with dopamine agonists and levodopa.
Last Update: 2012-04-10
Usage Frequency: 8
Quality:
aistiharhat aistiharhojen tiedetään olevan dopamiiniagonisti - ja levodopahoidon haittavaikutus.
hallucinations hallucinations are known as a side-effect of treatment with dopamine agonists and levodopa.
Last Update: 2012-04-10
Usage Frequency: 4
Quality:
mirapexinin vaikuttava aine pramipeksoli on dopamiiniagonisti, joka jäljittelee dopamiinin toimintaa.
the active substance in mirapexin, pramipexole, is a dopamine agonist, which imitates the action of dopamine.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
neupro sisältää rotigotiinia, joka jäljittelee dopamiinin toimintaa (dopamiiniagonisti) .
neupro contains rotigotine, which imitates the action of dopamine (dopamine agonist) .
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pramipexole tevan vaikuttava aine pramipeksoli on dopamiiniagonisti, joka jäljittelee dopamiinin tomintaa.
the active substance in pramipexole teva, pramipexole, is a dopamine agonist, which imitates the action of dopamine.
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
rotigotiini on parkinsonin taudin hoitoon tarkoitettu nonergoliininen d3/d2/d1 dopamiiniagonisti.
rotigotine is a non-ergolinic d3/d2/d1 dopamine agonist for the treatment of parkinson 's disease.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
leganton vaikuttava aine rotigotiini on dopamiiniagonisti, mikä tarkoittaa sitä, että se jäljittelee dopamiinin toimintaa.
the active substance in leganto, rotigotine, is a dopamine agonist, which means that it imitates the action of dopamine.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
vaikutusmekanismi ropiniroli on ei- ergotamiinirakenteinen d2/ d3 dopamiiniagonisti, joka stimuloi striataalisia dopamiinireseptoreita.
ropinirole is a non ergoline d2/ d3 dopamine agonist which stimulates striatal dopamine receptors.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
rotigotiini on parkinsonin taudin oireiden ja löydösten sekä levottomat jalat -oireyhtymän hoitoon tarkoitettu nonergoliininen dopamiiniagonisti.
rotigotine is a non-ergolinic dopamine agonist for the treatment of signs and symptoms of parkinson’s disease and restless legs syndrome.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
ensimmäisessä tutkimuksessa neupron tehokkuutta verrattiin lumelääkkeeseen ja toisessa tutkimuksessa sitä verrattiin ropiniroliin (toinen dopamiiniagonisti) ja lumelääkkeeseen.
in the first study, the effectiveness of neupro was compared with that of placebo (a dummy treatment) and in the second, it was compared with ropinirole (another dopamine agonist) and with placebo.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
psykoottisten oireiden hoidossa olantsapiini ei ollut plaseboa tehokkaampi.näiden tutkimusten sisäänottovaiheessa potilaiden parkinsonismin tuli olla hallinnassa pienimmällä tehokkaalla parkinsonlääkeannoksella (dopamiiniagonisti) .
in these trials, patients were initially required to be stable on the lowest effective dose of anti-parkinsonian medications (dopamine agonist) and to remain on the same anti-parkinsonian medications and dosages throughout the study.
Last Update: 2008-03-04
Usage Frequency: 18
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.